Goldentree Asset Management LP Takes Position in Ardent Health Partners, LLC (NYSE:ARDT)

Goldentree Asset Management LP purchased a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,248,611 shares of the company's stock, valued at approximately $22,897,000. Ardent Health Partners makes up 1.8% of Goldentree Asset Management LP's portfolio, making the stock its 19th biggest position. Goldentree Asset Management LP owned approximately 0.87% of Ardent Health Partners at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC acquired a new position in Ardent Health Partners during the third quarter valued at approximately $13,119,000. Seven Grand Managers LLC bought a new stake in shares of Ardent Health Partners during the 3rd quarter worth approximately $2,298,000. Financial Management Professionals Inc. acquired a new stake in shares of Ardent Health Partners in the 3rd quarter valued at approximately $50,000. BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners in the third quarter valued at $42,000. Finally, Charles Schwab Investment Management Inc. acquired a new position in Ardent Health Partners during the third quarter worth $526,000.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ARDT shares. Royal Bank of Canada reiterated an "outperform" rating and set a $23.00 target price on shares of Ardent Health Partners in a research note on Thursday, November 14th. KeyCorp started coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They set an "overweight" rating and a $24.00 target price for the company. Mizuho began coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued an "outperform" rating and a $20.00 price target on the stock. Morgan Stanley began coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set an "overweight" rating and a $27.00 price objective for the company. Finally, Leerink Partners upped their target price on Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a research report on Tuesday, November 12th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $21.82.

Ardent Health Partners Price Performance

ARDT traded up $0.04 on Friday, reaching $15.98. The stock had a trading volume of 66,018 shares, compared to its average volume of 356,945. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The firm's 50-day moving average price is $17.84. Ardent Health Partners, LLC has a fifty-two week low of $14.57 and a fifty-two week high of $20.72.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.